The Enterprise Value as of December 2024 (TTM) for NeoGenomics, Inc. (NEO) is 2.37B

According to NeoGenomics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.37B. This represents a change of 9.38% compared to the average of 2.16B of the last 4 quarters.

NeoGenomics, Inc. (NEO) Historical Enterprise Value (quarterly & annually)

How has NEO Enterprise Value performed in the past?

The mean historical Enterprise Value of NeoGenomics, Inc. over the last ten years is 2.04B. The current 2.37B Enterprise Value has changed 11.48% with respect to the historical average. Over the past ten years (40 quarters), NEO's Enterprise Value was at its highest in in the September 2021 quarter at 6.05B. The Enterprise Value was at its lowest in in the December 2014 quarter at 225.17M.

NeoGenomics, Inc. (NEO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NeoGenomics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeoGenomics, Inc. (NEO) Average Enterprise Value

How has NEO Enterprise Value performed in the past?

The current Enterprise Value of NeoGenomics, Inc. (NEO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

NeoGenomics, Inc. (NEO) Enterprise Value vs. Peers

How is NEO’s Enterprise Value compared to its peers?

NeoGenomics, Inc.’s Enterprise Value is less than Natera, Inc. (20.97B), less than Qiagen N.V. (10.89B), less than Neogen Corporation (3.40B), less than Guardant Health, Inc. (4.49B), greater than CareDx, Inc (1.06B), greater than Myriad Genetics, Inc. (1.29B), greater than Invitae Corporation (1.36B), greater than Castle Biosciences, Inc. (701.42M), less than Syneos Health, Inc. (7.24B), less than Mettler-Toledo International Inc. (28.05B), less than ICON Public Limited Company (20.22B), less than IQVIA Holdings Inc. (48.27B), less than Charles River Laboratories International, Inc. (12.03B), less than Sotera Health Company (5.83B), less than Olink Holding AB (publ) (3.16B), greater than Aclaris Therapeutics, Inc. (158.78M), less than Twist Bioscience Corporation (2.71B), greater than Biodesix, Inc. (244.39M),

Build a custom stock screener for NeoGenomics, Inc. (NEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoGenomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeoGenomics, Inc. (NEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeoGenomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.